Target intelligence / Profile preview

Frataxin pseudogene (none)

Target
none
Molecular classification
Other (pseudogene)
01

Overview

Frataxin pseudogene (ENSG00000249418) is a genomic DNA sequence that resembles the functional frataxin (FXN) gene but does not produce a functional protein product. Pseudogenes typically arise by gene duplication or retrotransposition and subsequently accumulate mutations that prevent them from expressing functional proteins. As such, frataxin pseudogene does not have a known biological function, is not implicated in disease, and is not a target for any therapeutic intervention. The functional frataxin gene, by contrast, codes for a mitochondrial protein involved in iron-sulfur cluster assembly and whose deficiency causes Friedreich's ataxia—a neurodegenerative disorder[1][3][2]. However, none of these properties apply to the pseudogene form. Key distinctions: This entry is for a pseudogene, not the protein-coding FXN gene or frataxin protein. If you want information on the functional, disease-relevant protein or drug target, you should query the canonical frataxin (FXN) gene, not a pseudogene locus.

Other names
FXN pseudogenefrataxin-likepossible FXN pseudogene
02

Mechanism of action

none (not applicable; pseudogenes are not targeted by mechanism-based drugs)

03

Biological functions

none (pseudogenes typically lack biological function; the parent gene, frataxin, is involved in mitochondrial iron-sulfur cluster biogenesis[1][3][2], but this is not expected for the pseudogene)
04

Disease associations

none (the parent, frataxin, is implicated in Friedreich’s ataxia[1][3][2], but the pseudogene has no established disease association)
05

Safety considerations

none (not a drug target or marker; no safety considerations are documented)
06

Interacting drugs

none (no drugs interact with a pseudogene; drugs targeting frataxin or its pathway would be unrelated)
07

Biomarkers

none (the functional frataxin protein is a biomarker in Friedreich’s ataxia[5], but not the pseudogene)

Beyond the preview

Go deeper on Frataxin pseudogene (none).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frataxin pseudogene (none).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call